Oct1 is required for mTOR-induced G1 cell cycle arrest via the control of p27Kip1 expression

Cell Cycle

Volumn 9, Issue 19, 2010, Pages 3933-3944

  Dalvai, Mathieu ^a,b   Schubart, Karin ^a   Besson, Arnaud ^b,c   Matthias, Patrick ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^b CNRS   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Cell cycle; mTOR; Oct1; Stress

Indexed keywords

AMINO ACID; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GLUCOSE; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; OCTAMER TRANSCRIPTION FACTOR 1;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; EMBRYO CELL; FIBROBLAST; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; WILD TYPE;

EID: 77958502590     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.19.13154     Document Type: Article

References (46)

1. Sturm RA, Das G, Herr W. The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. Genes Dev 1988; 2:1582-99.
2. Kang J, Shakya A, Tantin D. Stem cells, stress, metabolism and cancer: a drama in two Octs. Trends Biochem Sci 2009; 34:491-9.
3. Herr W, Sturm RA, Clerc RG, Corcoran LM, Baltimore D, Sharp PA, et al. The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2 and Caenorhabditis elegans unc-86 gene products. Genes Dev 1988; 2:1513-6.
4. Ryan AK, Rosenfeld MG. POU domain family values: flexibility, partnerships and developmental codes. Genes Dev 1997; 11:1207-25.
5. Verrijzer CP, Alkema MJ, van Weperen WW, Van Leeuwen HC, Strating MJ, van der Vliet PC. The DNA binding specificity of the bipartite POU domain and its subdomains. EMBO J 1992; 11:4993-5003.
6. LaBella F, Sive HL, Roeder RG, Heintz N. Cell cycle regulation of a human histone H2b gene is mediated by the H2b subtype-specific consensus element. Genes Dev 1988; 2:32-9.
7. Carbon P, Murgo S, Ebel JP, Krol A, Tebb G, Mattaj LW. A common octamer motif binding protein is involved in the transcription of U6 snRNA by RNA polymerase III and U2 snRNA by RNA polymerase II. Cell 1987; 51:71-9.
8. Das G, Henning D, Wright D, Reddy R. Upstream regulatory elements are necessary and sufficient for transcription of a U6 RNA gene by RNA polymerase III. EMBO J 1988; 7:503-12.
9. Kaushansky K, Shoemaker SG, O'Rork CA, McCarty JM. Coordinate regulation of multiple human lymphokine genes by Oct-1 and potentially novel 45 and 43 kDa polypeptides. J Immunol 1994; 152:1812-20. (Pubitemid 24075713)
10. Bertolino E, Reddy K, Medina KL, Parganas E, Ihle J, Singh H. Regulation of interleukin 7-dependent immunoglobulin heavy-chain variable gene rearrangements by transcription factor STAT5. Nat Immunol 2005; 6:836-43. (Pubitemid 43090470)
11. Delhase M, Castrillo JL, de la Hoya M, Rajas F, Hooghe-Peters EL. AP-1 and Oct-1 transcription factors downregulate the expression of the human PIT1/GHF1 gene. J Biol Chem 1996; 271:32349-58. (Pubitemid 26422276)
12. Scully KM, Jacobson EM, Jepsen K, Lunyak V, Viadiu H, Carriere C, et al. Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification. Science 2000; 290:1127-31.
13. Wu GD, Lai EJ, Huang N, Wen X. Oct-1 and CCAAT/enhancer-binding protein (C/EBP) bind to overlapping elements within the interleukin-8 promoter. The role of Oct-1 as a transcriptional repressor. J Biol Chem 1997; 272:2396-403. (Pubitemid 27058528)
14. Iademarco MF, McQuillan JJ, Dean DC. Vascular cell adhesion molecule 1: contrasting transcriptional control mechanisms in muscle and endothelium. Proc Natl Acad Sci USA 1993; 90:3943-7.
15. Cheng CK, Yeung CM, Hoo RL, Chow BK, Leung PC. Oct-1 is involved in the transcriptional repression of the gonadotropin-releasing hormone receptor gene. Endocrinology 2002; 143:4693-701.
16. Schwachtgen JL, Remacle JE, Janel N, Brys R, Huylebroeck D, Meyer D, et al. Oct-1 is involved in the transcriptional repression of the von willebrand factor gene promoter. Blood 1998; 92:1247-58. (Pubitemid 28369038)
17. Gstaiger M, Knoepfel L, Georgiev O, Schaffner W, Hovens CM. A B-cell coactivator of octamer-binding transcription factors. Nature 1995; 373:360-2.
18. Luo Y, Roeder RG. Cloning, functional characterization and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B. Mol Cell Biol 1995; 15:4115-24.
19. Strubin M, Newell JW, Matthias P. OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell 1995; 80:497-506.
20. Zheng L, Roeder RG, Luo Y. S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component. Cell 2003; 114:255-66. (Pubitemid 36936918)
21. Boulon S, Dantonel JC, Binet V, Vie A, Blanchard JM, Hipskind RA, et al. Oct-1 potentiates CREB-driven cyclin D1 promoter activation via a phospho-CREB-and CREB binding protein-independent mechanism. Mol Cell Biol 2002; 22:7769-79. (Pubitemid 35217288)
22. Fan W, Jin S, Tong T, Zhao H, Fan F, Antinore MJ, et al. BRCA1 regulates GADD45 through its interactions with the OCT-1 and CAAT motifs. J Biol Chem 2002; 277:8061-7. (Pubitemid 34968259)
23. Jin S, Fan F, Fan W, Zhao H, Tong T, Blanck P, et al. Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage. Oncogene 2001; 20:2683-90. (Pubitemid 32525299)
24. Tantin D, Schild-Poulter C, Wang V, Hache RJ, Sharp PA. The octamer binding transcription factor Oct-1 is a stress sensor. Cancer Res 2005; 65:10750-8. (Pubitemid 41713343)
25. Kang J, Gemberling M, Nakamura M, Whitby FG, Handa H, Fairbrother WG, et al. A general mechanism for transcription regulation by Oct1 and Oct4 in response to genotoxic and oxidative stress. Genes Dev 2009; 23:208-22.
26. Hirose T, Sowa Y, Takahashi S, Saito S, Yasuda C, Shindo N, et al. p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y. Oncogene 2003; 22:7762-73. (Pubitemid 37485535)
27. Feng Z, Zhang H, Levine AJ, Jin S. The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA 2005; 102:8204-9. (Pubitemid 40800067)
28. Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev 2004; 18:1926-45.
29. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006; 124:471-84.
30. Avruch J, Hara K, Lin Y, Liu M, Long X, Ortiz-Vega S, et al. Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase. Oncogene 2006; 25:6361-72. (Pubitemid 44596154)
31. Proud CG. mTOR-mediated regulation of translation factors by amino acids. Biochem Biophys Res Commun 2004; 313:429-36.
32. Suzuki N, Peter W, Ciesiolka T, Gruss P, Scholer HR. Mouse Oct-1 contains a composite homeodomain of human Oct-1 and Oct-2. Nucleic Acids Res 1993; 21:245-52. (Pubitemid 23151894)
33. Sebastiano V, Dalvai M, Gentile L, Schubart K, Sutter J, Arauzo Bravo M, et al. Oct1 regulates trophoblast development during early mouse embryogenesis. Submitted.
34. Todaro GJ, Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol 1963; 17:299-313.
35. Sauter P, Matthias P. Coactivator OBF-1 makes selective contacts with both the POU-specific domain and the POU homeodomain and acts as a molecular clamp on DNA. Mol Cell Biol 1998; 18:7397-409. (Pubitemid 28533059)
36. Boyd KE, Wells J, Gutman J, Bartley SM, Farnham PJ. c-Myc target gene specificity is determined by a post-DNAbinding mechanism. Proc Natl Acad Sci USA 1998; 95:13887-92. (Pubitemid 28523068)
37. Wang VE, Schmidt T, Chen J, Sharp PA, Tantin D. Embryonic lethality, decreased erythropoiesis and defective octamer-dependent promoter activation in Oct-1-deficient mice. Mol Cell Biol 2004; 24:1022-32. (Pubitemid 38112167)
38. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 1994; 372:570-3.
39. Besson A, Dowdy SF, Roberts JM. CDK Inhibitors: Cell Cycle Regulators and Beyond. Dev Cell 2008; 14:159-69.
40. 1-phase progression. Genes Dev 1999; 13:1501-12.
41. Pfeuffer I, Klein-Hessling S, Heinfling A, Chuvpilo S, Escher C, Brabletz T, et al. Octamer factors exert a dual effect on the IL-2 and IL-4 promoters. J Immunol 1994; 153:5572-85. (Pubitemid 24377693)
42. Kim U, Siegel R, Ren X, Gunther CS, Gaasterland T, Roeder RG. Identification of transcription coactivator OCA-B-dependent genes involved in antigen-dependent B cell differentiation by cDNA array analyses. Proc Natl Acad Sci USA 2003; 100:8868-73. (Pubitemid 36899190)
43. Kip1. Mol Cell Biol 1996; 16:6744-51.
44. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, et al. Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia and pituitary tumors. Cell 1996; 85:707-20. (Pubitemid 26181050)
45. Chen G, Yang N, Wang X, Zheng SY, Chen Y, Tong LJ, et al. Identification of p27/KIP1 expression level as a candidate biomarker of response to rapalogs therapy in human cancer. J Mol Med.
46. Kip1. J Biol Chem 285:11991-7.